Drew Senyei, MD, is a managing director at Enterprise Partners Venture Capital who leads the firm’s life science. See sector focus and contact routes.
Drew Senyei, MD, is a managing director at Enterprise Partners Venture Capital who leads the firm’s life science practice and invests in pharmaceuticals, biopharmaceuticals, diagnostics, medical devices, and consumer healthcare. His notable portfolio includes founding investments in NuVasive (a non-invasive orthopedic company) and early-stage bets in Ligand Pharmaceuticals, Nanogen, and Discovery Partners. Senyei’s distinctive thesis leverages his physician background to target novel core technologies in life sciences, often serving as a lead investor and taking board seats in portfolio companies.
StartupFundraising tracks this investor record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in La Jolla.
Investors like Drew Senyei · Full investor directory · Investor access · Company funding database